CASC3 and lung carcinoma: Recent studies of the direct mechanisms of Btz resistance were derived analyzed various tumor cell lines, including MM [10, 11], lymphoma [26], leukemia [9, 27], lung cancer [12], and hepatocellular carcinoma [14], with Btz.